Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

VFC's Stock House: Synergy Pharmaceuticals (SGYP) Ready To Roll

(EMAILWIRE.COM, May 22, 2012 ) New York, NY -- VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, reported today that Synergy Pharmaceuticals (SGYP) may be in a position to realize significant share price gains over the coming months.



Synergy Pharmaceuticals (SGYP) ran to over seven dollars last month on increasing volume as the company's billion dollar potential took shape and numerous analysts jumped on board with encouraging write-ups and bold price predictions.



Synergy also received a boost when its chief competitor, Ironwood Pharmaceuticals (IRWD) received a setback at the FDA that allows SGYP an extra three months to play catch up in the race to commercialization for each company's respective product candidate, both of which target the same indication. Synergy's product Plecanatide, however, has a much more favorable side effect profile, making the Ironwood setback that much more of a key factor when discussing future market potential.



Both products, Synergy's Plecanatide and Ironwood's Linaclotide, are being developed to treat chronic idiopathic constipation (CIC) and constipation-predominant irritable bowel syndrome (IBS-C). Linaclotide is already before the FDA for review, although the review was delayed by three months, as mentioned before, while Phase II/III Plecanatide results are due out later this year.



The head start to market may provide Ironwood with a distinct advantage, but the advantage might not last too long when Plecanatide shows up on the scene.



During the Linaclotide trials, the drug was successful in alleviating symptoms relating to IBS-C and CIC when compared to a placebo, but the kicker is that patients experienced side effects that included cases of extreme diarrhea, essentially reversing the symptom being treated. Some cases of diarrhea were so bad that 6% of the patients decided to abandon the trial altogether.



On the open market - with a competing product out there for which there have been no such cases noted - that means those patients would likely switch to the alternative, in this case Plecanatide, that is not associated with carrying around a roll of Charmin' Soft at all times.



For full report visit: http://vfcsstockhouse.com/blog/article/-synergy-pharmaceuticals-sgyp-may-be-ready-to-roll



For full report and opinion visit: http://vfcsstockhouse.com/blog/article/-the-facebook-fb-ipo-don-t-believe-the-hype



Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse



'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213



About VFCsStockHouse.com:



VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFCs Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.



For full disclaimer visit: http://vfcsstockhouse.com







VFC's Stock House
VFC
240-786-2111
vfc@vfcsstockhouse.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

Chinese polluters to face more business, financing restrictions
27 Jul 2016 at 9:22pm

Chinese firms guilty of exceeding emissions limits or building plants without environmental permits will face tougher punishments including credit bans and land use restrictions, the country's environmental ministry said late on Wednesday. China has been cracking down on polluting enterprises, raising fines and threatening criminal action against persistent offenders, but regulators have long struggled to impose rules on powerful industrial enterprises and local governments anxious to protect revenue and jobs. The Ministry of Environmental Protection said in a notice published on its website that it has signed a cooperation agreement with 30 government departments, including the central bank, to broaden the range of punishments for offenders as well as improve information sharing.



Fosun agrees to buy KKR-backed Indian drugmaker for $1.4 billion: source
27 Jul 2016 at 8:37pm

Shanghai Fosun Pharmaceutical Group Co Ltd has agreed to buy Gland Pharma - backed by KKR & Co LP - for about $1.4 billion, a person with direct knowledge of the matter said, in India's largest inbound acquisition this year. The deal would be the first major move by the Fosun group since Guo Guangchang, founder of flagship holding firm Fosun International Ltd and one of China's best-known entrepreneurs, briefly went missing late last year. The acquisition would also underscore the positive outlook for drugmakers in India, which is a major global supplier and counts the United States as its largest export market helped by lower manufacturing and labor costs.



President Reagan's would-be killer Hinckley to go free
27 Jul 2016 at 8:23pm

U.S. District Judge Paul Friedman said Hinckley, 61, who was found not guilty by reason of insanity in a 1982 trial, no longer posed a danger to himself or others. "Since 1983, when he last attempted suicide, he has displayed no symptoms of active mental illness, exhibited no violent behavior, shown no interest in weapons, and demonstrated no suicidal ideation," Friedman said of Hinckley in a 103-page opinion.



Army secretary touts importance of mental health
27 Jul 2016 at 7:38pm

HONOLULU (AP) ? Army Secretary Eric Fanning says the Army is paying more attention to behavioral health and making sure anyone who's injured while defending the nation gets the treatment they need.



Florida identifies two more Zika cases not related to travel
27 Jul 2016 at 7:09pm

By Julie Steenhuysen CHICAGO (Reuters) - The Florida health department said on Wednesday it was investigating another two cases of Zika not related to travel to a place where the virus is being transmitted, raising the possibility of local Zika transmission in the continental United States. The Florida health department said it has identified an additional case of Zika in Miami-Dade County, where it was already investigating a possible case of Zika not related to travel, and another case in Broward County, where it has been investigating a non-travel related case. "Evidence is mounting to suggest local transmission via mosquitoes is going on in South Florida," said CDC spokesman Tom Skinner said.



To reverse damage of sitting, take a brisk, hour-long walk
27 Jul 2016 at 7:04pm

LONDON (AP) ? If you spend all day sitting on your rear end, then you might want to schedule some time for a brisk walk ? just make sure you can spare at least an hour.


Justice Department probes Alere over Medicare, Medicaid billing
27 Jul 2016 at 5:35pm
(Reuters) - Diagnostic-testing company Alere Inc has received a U.S. Department of Justice subpoena seeking patient-billing records related to Medicare, Medicaid and Tricare, the company said on Wednesday. The subpoena, which was sent to Alere's Toxicology unit on July 1, asked for billing records dating back to 2010 for patient samples tested at the company's Texas pain management laboratory, Alere said in a statement. "So, the shares are actually recovering from getting crushed earlier in the day." Alere said it was fully cooperating with the investigation and believed that matters related to the subpoena were not material.

Background noise can make it harder for toddlers to learn words
27 Jul 2016 at 5:24pm
?Either turning off the TV and radio or turning them down may help language development,? McMillan said by email. To understand how background noise influences language development in toddlers, McMillan and colleagues did three experiments with a total of 106 kids ranging in age from 22 to 30 months. In the first experiment, 40 kids aged 22 to 24 months heard either louder or softer background speech when learning the new words.

Induced labor not linked to higher autism risk
27 Jul 2016 at 5:23pm
By Lisa Rapaport (Reuters Health) - Inducing labor doesn?t appear to increase the baby's odds of autism, a new study suggests. Researchers examined data on more than 1.3 million births in Sweden and found about 3.5% of babies born after induction were diagnosed with autism by age 20, compared with 2.5% of other infants. This translates into a roughly 19% greater risk of autism with induced labor, which is statistically significant.

Women with later start to periods, menopause more likely to reach age 90
27 Jul 2016 at 5:21pm
By Andrew M. Seaman (Reuters Health) - Women with later menarche and later menopause are more likely to reach age 90 than those whose reproductive milestones come at earlier ages, suggests a new study. "People have always wondered whether the timing of reproductive events affect longevity, but no study to date has evaluated that relationship," said lead author Aladdin Shadyab, of the University of California, San Diego School of Medicine. The research team used data collected from 16,251 participants in the Women's Health Initiative, starting between 1993 and 1998 and continuing until August 2014.

Exclusive: Advent, CVC bid for inVentiv ahead of IPO: sources
27 Jul 2016 at 4:37pm
By Carl O'Donnell and Greg Roumeliotis (Reuters) - Buyout firms Advent International and CVC Capital Partners have made offers to acquire inVentiv Group Holdings, a pharmaceutical research firm seeking to go public at a valuation of over $4 billion including debt, people familiar with the matter said. The bids illustrate the private equity sector's insatiable appetite for contract research organizations such as inVentiv, which have benefited in recent years from the pharmaceutical companies' drive to cut costs, reduce clinical trial times and expand their research and development presence around the world. Thomas H. Lee Partners, the private equity firm that owns inVentiv, will decide by next week whether to press ahead with an initial public offering (IPO) for inVentiv or agree to an outright sale of the company with one of the two private equity firms, the people said on Wednesday.

UK health service under fire over access to hepatitis C drugs
27 Jul 2016 at 4:05pm
British health authorities improperly restrict access to expensive new hepatitis C drugs that can cure the liver-destroying disease, patient groups and a leading medical journal charged on Thursday. Despite the clear benefits of the drugs, the National Health Service in England rations the drugs to just 10,000 people with the virus each year, campaigners said. The Hepatitis C Trust said it was now seeking a judicial review of NHS England?s decision and the court is considering whether to grant permission for the case to go ahead.

Rauner: Illinois doing all it can on Legionnaires' cases
27 Jul 2016 at 3:58pm
QUINCY, Ill. (AP) ? Illinois Gov. Bruce Rauner said Wednesday that the state is doing everything it can to prevent the spread of Legionnaires' disease at a veterans home where an outbreak last year sickened 53 people, including 12 who died.

Lack of exercise costs world $67.5 bln and 5 million lives a year
27 Jul 2016 at 3:30pm
* Physical inactivity linked to 5 million deaths a year * Sitting for eight hours or more raises mortality risk * Experts say at least an hour a day of exercise is ideal By Kate Kelland, Health and Science Correspondent LONDON, July 27 (Reuters) - A study of one million people has found that physical inactivity costs the global economy $67.5 billion a year in healthcare and productivity losses, but an hour a day of exercise could eliminate most of that. Sedentary lifestyles are linked to increased risks of heart disease, diabetes and cancer, researchers found, but activity - such as brisk walking - could counter the higher likelihood of early death linked with sitting for eight or more hours a day. Such inactivity is estimated to cause more than 5 million deaths a year - almost as many as smoking, which the World Health Organization (WHO) says kills 6 million a year.


Teva, Allergan win U.S. antitrust approval for generics deal
27 Jul 2016 at 2:42pm

WASHINGTON (Reuters) - Teva Pharmaceutical Industries Ltd won U.S. antitrust approval to purchase Allergan Plc's generics business, after agreeing to divest 79 generic drugs to rival firms, the Federal Trade Commission said on Wednesday.


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC